SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029126
Filing Date
2020-10-22
Accepted
2020-10-22 20:53:28
Documents
2
Period of Report
2020-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1546
2 EX-24 DOCUMENT attachment1.htm EX-24 3954
  Complete submission text file 0000899243-20-029126.txt   6867
Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39634 | Film No.: 201255864

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations